Editorial: New Advances in Non-small Cell Lung Cancer Management: Immune Modulation and Targeted Therapies

par Thierry Berghmans, Jacques Cadranel, Bogdan Grigoriu
Publié 2021

Association of CSMD1 with Tumor Mutation Burden and Other Clinical Outcomes in Gastric Cancer

par Wang X, Wang S, Han Y, Xu M, Li P, Ke M, Teng Z, Huang P, Diao Z, Yan Y, Meng Q, Kuang Y, Zheng W, Liu H, Liu X, Jia B
Publié 2021

Immunotherapy for the Treatment of Breast Cancer: Emerging New Data

par Mina LA, Lim S, Bahadur SW, Firoz AT
Publié 2020

Cure the Incurable? Recent Breakthroughs in Immune Checkpoint Blockade for Hepatocellular Carcinoma

par Pei-Yi Chu, Shih-Hsuan Chan
Publié 2021

Improving Immunotherapy Efficacy in Soft-Tissue Sarcomas: A Biomarker Driven and Histotype Tailored Review

par Matthieu Roulleaux Dugage, Elise F. Nassif, Antoine Italiano, Antoine Italiano, Rastislav Bahleda
Publié 2021

Adverse Events Induced by PD-1/PD-L1 Inhibitors: A Real-World Single-Centre Experience with a Management-Based Approach

par Grimaud F, Penaranda G, Stavris C, Retornaz F, Brunel V, Cailleres S, Pegliasco H, Le Treut J, Grisoni V, Coquet E, Chiche L, Rognon A
Publié 2021

Molecular genetic portrait of non-small cell lung cancer in Tambov region: regional experience

par N. A. Ognerubov, V. D. Sychev, N. A. Kozlova, V. L. Chang
Publié 2020